We are live on ! Find out more
MA

Montag & Associates Portfolio holdings

AUM $2.37B
1-Year Est. Return 28.86%
This Fund
S&P 500
This Quarter Est. Return
+7.68%
1 Year Est. Return
+28.86%
3 Year Est. Return
+82.88%
5 Year Est. Return
+98.91%
10 Year Est. Return
+378.43%
AUM
$2.17B
AUM Growth
+$121M
Cap. Flow
-$10.8M
Cap. Flow %
-0.5%
Top 10 Hldgs %
31.68%
Holding
1,161
New
216
Increased
273
Reduced
240
Closed
42

Top Buys

Rank Stock Value
1
URI icon
United Rentals
URI
+$5.65M
2
VGIT icon
Vanguard Intermediate-Term Treasury ETF
VGIT
+$3.6M
3
MSFT icon
Microsoft
MSFT
+$2.6M
4
CDNS icon
Cadence Design Systems
CDNS
+$2.57M
5
ETN icon
Eaton
ETN
+$1.95M

Top Sells

Rank Stock Value
1
CRM icon
Salesforce
CRM
+$4.76M
2
APH icon
Amphenol
APH
+$4.23M
3
ZM icon
Zoom
ZM
+$3.41M
4
ESS icon
Essex Property Trust
ESS
+$3.35M
5
GS icon
Goldman Sachs
GS
+$3.01M

Sector Composition

Rank Sector Weight
1 Technology 17.72%
2 Financials 9.52%
3 Consumer Discretionary 7.6%
4 Industrials 7.26%
5 Healthcare 6.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CPRX
1101
DELISTED
Catalyst Pharmaceutical
CPRX
$355 ﹤0.01%
+18
New +$370
DNTH icon
1102
Dianthus Therapeutics
DNTH
$6.09B
$355 ﹤0.01%
+9
New +$230
PGX icon
1103
Invesco Preferred ETF
PGX
$3.79B
$348 ﹤0.01%
30
-419
-93% -$4.8K
KYMR icon
1104
Kymera Therapeutics
KYMR
$8.94B
$340 ﹤0.01%
+6
New +$271
OKLO
1105
Oklo
OKLO
$8.42B
$335 ﹤0.01%
+3
New +$235
ALKS icon
1106
Alkermes
ALKS
$8.25B
$330 ﹤0.01%
+11
New +$310
CYTK icon
1107
Cytokinetics
CYTK
$10.4B
$330 ﹤0.01%
+6
New +$247
PSO icon
1108
Pearson
PSO
$9.9B
$326 ﹤0.01%
+23
New +$331
ANAB icon
1109
AnaptysBio
ANAB
$1.68B
$276 ﹤0.01%
+9
New +$207
CRTO icon
1110
Criteo S.A. Ordinary Shares
CRTO
$923M
$272 ﹤0.01%
+12
New +$281
EWTX icon
1111
Edgewise Therapeutics
EWTX
$4.73B
$260 ﹤0.01%
+16
New +$227
VRDN icon
1112
Viridian Therapeutics
VRDN
$2.67B
$259 ﹤0.01%
+12
New +$216
LNTH icon
1113
Lantheus
LNTH
$6.59B
$257 ﹤0.01%
+5
New +$312
LKFT
1114
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.77B
$208 ﹤0.01%
+6
New +$192
AVBP icon
1115
ArriVent BioPharma
AVBP
$1.44B
$203 ﹤0.01%
+11
New +$216
APGE icon
1116
Apogee Therapeutics
APGE
$10.2B
$159 ﹤0.01%
+4
New +$153
NEXT icon
1117
NextDecade
NEXT
$1.78B
$102 ﹤0.01%
+15
New +$145
MLTX icon
1118
MoonLake Immunotherapeutics
MLTX
$1.55B
$51 ﹤0.01%
+7
New +$365
ERNA icon
1119
Eterna Therapeutics
ERNA
$4.91M
– –
0
– –
AL
1120
DELISTED
Air Lease Corp
AL
– –
-18
Closed -$1.07K
ANSS
1121
DELISTED
Ansys
ANSS
– –
-173
Closed -$60.7K
AZEK
1122
DELISTED
The AZEK Co
AZEK
– –
-21
Closed -$1.13K
BFAM icon
1123
Bright Horizons
BFAM
$3.86B
– –
-7
Closed -$908
BIDU icon
1124
Baidu
BIDU
$37.2B
– –
-10
Closed -$858
BLW icon
1125
BlackRock Limited Duration Income Trust
BLW
$493M
– –
-1,410
Closed -$20K
43 44
45
46 47

Similar funds

SCA
STALEY CAPITAL ADVISERS Pittsburgh, Pennsylvania $2.36B AUM 23.72% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
HFM
Harvest Fund Management Beijing, China $2.35B AUM 49.85% 1-Year Est. Return
CC
Capital Counsel New York $2.35B AUM 21.34% 1-Year Est. Return
ROIC
Route One Investment Company San Francisco, California $2.35B AUM 11.7% 1-Year Est. Return
RG
Renaissance Group Covington, Kentucky $2.39B AUM 27.81% 1-Year Est. Return
DSCM
Divisadero Street Capital Management Miami, Florida $2.39B AUM 134.55% 1-Year Est. Return
MC
Moors & Cabot Boston, Massachusetts $2.34B AUM 30.42% 1-Year Est. Return

Montag & Associates's Q3 2025 Portfolio in Review

As of Q3 2025, Montag & Associates held 1,161 positions worth $2.17B, up 5.9% from $2.05B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Montag & Associates's Q3 2025 filing shows 216 new, 273 increased, 240 reduced and 42 closed positions. Its largest new stake was Toll Brothers: 8,754 shares worth $1.21M. The largest sale was Salesforce, an estimated $4.76M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Montag & Associates's largest Q3 2025 buy was Toll Brothers: 8,754 shares worth $1.21M.
  • Montag & Associates added most to United Rentals in Q3 2025, an estimated $5.65M increase.
  • Montag & Associates's biggest Q3 2025 reduction was Salesforce, cutting an estimated $4.76M.
  • Montag & Associates fully exited Zoom in Q3 2025, selling an estimated $3.41M.
  • Montag & Associates's ten largest holdings make up 32% of its $2.17B portfolio in Q3 2025.
  • Montag & Associates opened 216 new positions and closed 42 in Q3 2025.
  • Montag & Associates's portfolio value rose 5.9% quarter-over-quarter to $2.17B.

Based on Montag & Associates's 13F filing for Q3 2025, filed 12 Nov 2025.